Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

SISU L-Arginine 750mg (April 05, 2006)

Starting date:
April 05, 2006
Posting date:
June 12, 2006
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2006A132

Reason

The Natural Health Products Directorate (NHPD) has issued letters to all L-arginine product licence holders dated March 31, 2006, advising of new information published in the Journal of the American Medical Association of possible increased mortality in patients taking natural health products containing L-arginine, when sold as a single ingredient, following an acute myocardial infarction. NHPD no longer considers theses products safe for consumers with cardiovascular diseases and related disorders without a contraindication warning statements on the label. The recommended contraindication is to state, " Do not use if you have had a myocardial infarction (heart attack)".

Depth of distribution

Distributed across Canada.

Affected products

SISU L-Arginine 750mg

DIN, NPN, DIN-HIM

NPN 80000156

Dosage form

Capsule

Strength

  • 750 mg / Capsule

Lot or serial number

55773, 47044

Companies

Recalling Firm
Sisu Inc.
104A - 3430 Brighton Avenue
Burnaby British Columbia
Canada V5A 3H4
Marketing Authorization Holder
Sisu Inc.
104A - 3430 Brighton Avenue
Burnaby British Columbia
Canada V5A 3H4